Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Leonard
Search for Low Mass Vector Resonances Decaying Into Quark-Antiquark Pairs in Proton-Proton Collisions at S = 13 $$ \Sqrt{s}=13 $$ TeV
Journal of High Energy Physics
High Energy Physics
Nuclear
Studies of Jet Mass in Dijet and W/Z + Jet Events
Journal of High Energy Physics
High Energy Physics
Nuclear
Erratum To: Comparison of the Z/Γ* + Jets to Γ + Jets Cross Sections in Pp Collisions at S = 8 $$ \Sqrt{s}=8 $$
Journal of High Energy Physics
High Energy Physics
Nuclear
Search for a Heavy Higgs Boson Decaying to a Pair of W Bosons in Proton-Proton Collisions at S$$ \Sqrt{s} $$ = 13 TeV
Journal of High Energy Physics
High Energy Physics
Nuclear
Search for New Particles Decaying to a Jet and an Emerging Jet
Journal of High Energy Physics
High Energy Physics
Nuclear
Measurements of T T ¯ $$ \Mathrm{t}\overline{\mathrm{t}} $$ Differential Cross Sections in Proton-Proton Collisions at S = 13 $$ \Sqrt{\mathrm{s}}=13 $$ TeV Using Events Containing Two Leptons
Journal of High Energy Physics
High Energy Physics
Nuclear
Augment: Relapsed/Refractory Indolent NHL Patients Were More Sensitive to Next Treatment Following Lenalidomide/Rituximab (R2 ) Than Rituximab/Placebo
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Augment Phase Iii Study: Lenalidomide/Rituximab (R2 ) Improved Efficacy Over Rituximab/Placebo in Relapsed/Refractory Follicular Patients Irrespective of Pod24 Status
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Post Hoc Analyses of Patients With Relapsed/Refractory Marginal Zone Lymphoma Who Received Lenalidomide Plus Rituximab (R2 ) vs Rituximab/Placebo (Augment)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Measurement of the Differential Cross Section for Isolated Prompt Photon Production Inppcollisions at 7 TeV
Physical Review D
‹
1
2
3
4
›